DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Ciluprevir
Ciluprevir
Antiviral Chemistry & Chemotherapy's Current Antiviral Agents Factfile 2006
Novel HCV Inhibitors
Design and Synthesis of Hepatitis C Virus NS3 Protease Inhibitors
Reviews in Basic and Clinical Gastroenterology
Targets for Antiviral Therapy of Hepatitis C
Mechanisms of Substrate Recognition by HCV NS3/4A Protease Provide Insights Into Drug Resistance: a Dissertation
Targeting Drug Resistance in HCV NS3/4A Protease: Mechanisms and Inhibitor Design Strategies
Proprotein Convertases and Serine Protease Inhibitors: Developing Novel Indirect-Acting Antiviral Strategies Against Hepatitis C Virus
Hepatitis C Viral Replication Complex
HCV NS3/4A Protease and Its Emerging Inhibitors
WO 2017/004022 A2 5 January 2017 (05.01.2017) P O P C T
Antiviral Therapy for Hepatitis C Virus: Beyond the Standard of Care
Repurposing of FDA Approved Drugs
Computational Analysis of Macrolides As SARS-Cov-2 Main Protease
Use of QSAR Global Models and Molecular Docking for Developing New Inhibitors of C-Src Tyrosine Kinase
Treatmentupdate 215 Vol
The 2014 Short Guide to Hepatitis C
Antiviral Activity, Safety, and Pharmacokinetics of Danoprevir/Ritonavir Plus PEG-IFN Α-2A/RBV in Hepatitis C Patients
Top View
Computationally Repurposed Drugs and Natural Products Against RNA Dependent RNA Polymerase As Potential COVID-19 Therapies
Current and Future Treatment Options for HCV
In Silico Evaluation of the Effectivity of Approved Protease Inhibitors
201917Orig1s000
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
New HCV Therapies on the Horizon
"The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances" WHO/EMP/QSM/2009.3
Acute Disruption of the Synaptic Vesicle Membrane Protein Synaptotagmin 1 Using Knockoff in Mouse Hippocampal Neurons Jason D Vevea1,2, Edwin R Chapman1,2*
A Drug Repurposing Screen Identifies Hepatitis C Antivirals As Inhibitors of the SARS-Cov-2 Main 2 Protease
Remdesivir from Wikipedia, the Free Encyclopedia
Synthesis and Kinetic Analysis of HCV NS3/4A Protease Inhibitors
Hepatitis C Virus NS3/4A Protease Inhibitors: a Light at the End of the Tunnel
ESI) for Molecular Omics
HCV – STAT-C Era of Therapy Christian Markus Lange, Christoph Sarrazin, Stefan Zeuzem
Inhibitor Potency and Oral Bioavailability 367 Acquired
Supplemental Table 1: Inclusion and Exclusion Criteria
Repurposing of Known Anti-Virals As Potential Inhibitors for SARS-Cov-2 Main Protease Using Molecular Docking Analysis